Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Current Pharmaceutical Design|May 29, 2003
Central pre-proglucagon derived peptides: opportunities for treatment of obesityPhilip J Larsen, Niels Vrang, Mads Tang-ChristensenBrain Research|April 17, 2007
Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nucleiNiels Vrang, Mikkel Hansen, Philip Just Larsen, et al.Brain Research|February 16, 2008
The putative neuropeptide TAFA5 is expressed in the hypothalamic paraventricular nucleus and is regulated by dehydrationSarah Juel Paulsen, Mads Tang Christensen, Niels Vrang, et al.Acta Pharmacologica Sinica|February 4, 2012
Laboratory animals as surrogate models of human obesityCecilia Nilsson, Kirsten Raun, Fei-fei Yan, et al.Brain Research|February 20, 2003
Hypothalamic cocaine-amphetamine regulated transcript (CART) is regulated by glucocorticoidsNiels Vrang, Philip J Larsen, Mads Tang-Christensen, et al.Current Pharmaceutical Design|May 29, 2003
Ghrelin as a potential anti-obesity targetTamas L Horvath, Tamara Castañeda, Mads Tang-Christensen, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 18, 2006
PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesityNiels Vrang, Andreas Nygaard Madsen, Mads Tang-Christensen, et al.Endocrinology|July 3, 2004
Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in ratsMads Tang-Christensen, Niels Vrang, Sylvia Ortmann, et al.Brain Research|November 21, 2007
Upregulation of the brainstem preproglucagon system in the obese Zucker ratNiels Vrang, Philip Just Larsen, Per Bo Jensen, et al.Cell Metabolism|March 19, 2019
Case Reports of Pre-clinical Replication Studies in Metabolism and DiabetesMatthias von Herrath, Philippe P Pagni, Kevin Grove, et al.Pageof 3